Insight
AI Washing Enforcement Continues, Highlighting Risks to Companies and Investors
by David Rhinesmith, Bradley Marcus, Sarah Schaedler and Jackson Hagen
5 minute read | July.02.2024

by David Rhinesmith, Bradley Marcus, Sarah Schaedler and Jackson Hagen
5 minute read | July.02.2024
by Emily S. Tabatabai, Shannon Yavorsky, Nicholas Farnsworth, Matthew D. LaBrie, James Chou and Jared Mark
5 minute read | April.17.2024
Over 5,000 privacy professionals from around the world gathered in Washington, D.C. this month for the IAPP Global Privacy Summit 2024.
by Dr. André Zimmermann LL.M., Marianna Urban and Jonas Banse
2 minute read | September.13.2024
by Andrew Cook, Rob McKenna, Brian T. Moran and Adam Braun
5 minute read | April.19.2024
While Congress and states slowly enact AI regulations, state attorneys general already have broad statutory authority to enforce AI.
by Thora Johnson, Alyssa Wolfington, Amy M. Joseph, Jeremy D. Sherer, Emily Brodkin and Melania Jankowski
3 minute read | September.24.2024
by Bradley Marcus and David Rhinesmith
6 minute read | March.25.2024
The SEC settled charges against two investment advisers for false claims of using AI to inform investment decisions.
by Bradley Marcus and Michael Rosenberg
6 minute read | June.22.2023
by Amanda Lawrence and Caroline Stapleton
4 minute read | July.07.2023
The three steps financial institutions should follow to manage artificial intelligence (AI) model risk.
by John Coleman, Amanda Lawrence, John (Jay) Williams, Brian Bartholomay and Ronald Williams
11 minute read | July.06.2023
Since 2011, the Consumer Financial Protection Bureau has enforced actions against companies, recovering billions. CIDs demand docs, testimony.
by Julia Apostle, Dr. Christian Schröder and Tobias Stephan
3 minute read | March.14.2025
1 minute watch | March.26.2025
by Georgia C. Ravitz, Shari Esfahani, Stephen Thau, Thora Johnson, Jeremy D. Sherer and Amy M. Joseph
2 minute read | January.13.2025
The FDA issued draft guidance on assessing AI model credibility for drug safety, effectiveness, and quality in regulatory decisions.